For the quarter ending 2025-09-28, DNUT had $9,329K increase in cash & cash equivalents over the period. $15,544K in free cash flow.
| Cash Flow | 2025-09-28 | 2025-06-29 |
|---|---|---|
| Net (loss)/income | -20,131 | -474,523 |
| Depreciation and amortization expense | 33,446 | 69,683 |
| Deferred and other income taxes | -6,611 | -30,785 |
| Loss on divestiture of insomnia cookies | - | 11,501 |
| Goodwill impairment | 0 | 355,958 |
| Other asset impairments and lease termination charges | 4,805 | 51,136 |
| Loss on disposal of property and equipment | -1,063 | -403 |
| (gain)/loss on divestiture of insomnia cookies | 11,501 | - |
| Gain (loss) on sale of properties | 1,063 | - |
| Gain on remeasurement of equity method investment | 0 | - |
| Gain on sale-leaseback | 0 | 6,749 |
| Share-based compensation | 774 | 7,237 |
| Change in accounts and notes receivable allowances | 94 | 986 |
| Inventory write-off | 4,923 | 1,495 |
| Amortization related to settlement of interest rate swap derivatives | 0 | 0 |
| Other | 1,907 | -2,224 |
| Change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments | -26,889 | 41,943 |
| Net cash (used for)/provided by operating activities | 42,282 | -53,377 |
| Purchase of property and equipment | 26,738 | 54,106 |
| Proceeds from sale-leaseback | 0 | 10,882 |
| Acquisition of shops and franchise rights from franchisees, net of cash acquired | 0 | - |
| Purchase of equity method investment | 858 | 2,140 |
| Net proceeds from divestiture of insomnia cookies | 0 | 75,000 |
| Principal payment received from loan to insomnia cookies | 0 | - |
| Principal payments received from loans to franchisees | 0 | 1,202 |
| Disbursement for loan receivable | 0 | 0 |
| Other investing activities | -78 | -99 |
| Net cash provided by investing activities | -27,518 | 30,937 |
| Proceeds from the issuance of debt | 144,126 | 516,900 |
| Repayment of long-term debt and lease obligations | 120,687 | 485,894 |
| Payment of financing costs | 0 | 825 |
| Proceeds from structured payables | 44,298 | 198,052 |
| Payments on structured payables | 71,190 | 199,228 |
| Capital contribution by shareholders, net of loans issued | 0 | 0 |
| Proceeds from sale of noncontrolling interest in subsidiary | 0 | - |
| Distribution to shareholders | 0 | 11,934 |
| Payments for repurchase and retirement of common stock | 397 | 787 |
| Distribution to noncontrolling interest | 0 | 36 |
| Net cash provided by/(used for) financing activities | -3,850 | 16,248 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -1,585 | -1,300 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | 9,329 | -7,492 |
| Cash and cash equivalents at beginning of period | 29,315 | - |
| Cash and cash equivalents at end of period | 31,152 | - |
Krispy Kreme, Inc. (DNUT)
Krispy Kreme, Inc. (DNUT)